World's Best Scientists 2026 revealed!
Award Badge
Neuroscience
Poland
2026

D-Index & Metrics

Neuroscience

D-Index
63
Citations
11390
World Ranking
3441
National Ranking
3

Research.com Recognitions

  • 2026 - Research.com Neuroscience in Poland Leader Award

Best Publications

  • Glutamate-based antidepressants: 20 years on

    Phil Skolnick;Piotr Popik;Piotr Popik;Ramon Trullas

  • Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression.

    P. Skolnick;R. T. Layer;P. Popik;G. Nowak

  • Adenosine A3 receptor stimulation and cerebral ischemia

    Dag K.J.E. Von Lubitz;Rick C.-S. Lin;Piotr Popik;Margaret F. Carter

  • Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments.

    I A Paul;G Nowak;R T Layer;P Popik

  • Low doses of oxytocin facilitate social recognition in rats.

    Piotr Popik;Jerzy Vetulani;Jan M. van Ree

  • 100 years of ibogaine: neurochemical and pharmacological actions of a putative anti-addictive drug.

    P Popik;R T Layer;P Skolnick

  • Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study.

    Marcin Siwek;Dominika Dudek;Ian A. Paul;Magdalena Sowa-Kućma

  • Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests.

    I.V. Belozertseva;T. Kos;P. Popik;W. Danysz

  • Antidepressant-like actions of DOV 21,947: a “triple” reuptake inhibitor

    Phil Skolnick;Piotr Popik;Aaron Janowsky;Bernard Beer

  • The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans.

    Adam Bisaga;Sandra D. Comer;Amie S. Ward;Piotr Popik

  • Oxytocin but not vasopressin facilities social recognition following injection into the medial preoptic area of the rat brain

    Piotr Popik;Jan M. van Ree

  • Laughing Rats Are Optimistic

    Rafal Rygula;Helena Pluta;Piotr Popik;Piotr Popik

  • In search of a new pharmacological treatment for drug and alcohol addiction: N-methyl-d-aspartate (NMDA) antagonists

    Adam Bisaga;Piotr Popik

  • Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715)

    Richard T. Layer;Piotr Popik;Tia Olds;Phil Skolnick

  • The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence

    Piotr Popik;Phil Skolnick

  • Morphine conditioned reward is inhibited by MPEP, the mGluR5 antagonist.

    P Popik;M Wróbel

  • Serum zinc level in depressed patients during zinc supplementation of imipramine treatment.

    Marcin Siwek;Dominika Dudek;Małgorzata Schlegel-Zawadzka;Agnieszka Morawska

  • Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal models.

    Aleksandra Kłodzińska;Ewa Chojnacka-Wójcik;Agnieszka Pałucha;Piotr Brański

  • Inhibition of Reinforcing Effects of Morphine and Motivational Aspects of Naloxone-Precipitated Opioid Withdrawal by N-Methyl-d-aspartate Receptor Antagonist, Memantine

    Piotr Popik;Wojciech Danysz

  • NMDA antagonist properties of the putative antiaddictive drug, ibogaine.

    P Popik;R T Layer;L H Fossom;M Benveniste

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Recently Published Articles